Literature DB >> 29292589

Anticholinergic burden and 1-year mortality among older patients discharged from acute care hospital.

Fabrizia Lattanzio1, Francesco Corica2, Roberto Schepisi2, Diana Amantea3, Francesco Bruno3, Annalisa Cozza1, Graziano Onder4, Stefano Volpato5, Antonio Cherubini1, Carmelinda Ruggiero6, Marcello G Maggio7, Andrea Corsonello1.   

Abstract

AIM: The association between anticholinergic burden and mortality is controversial. We aimed to investigate whether the anticholinergic cognitive burden (ACB) score predicts 1-year mortality in older patients discharged from acute care hospitals.
METHODS: Our series consisted of 807 hospitalized patients aged ≥65 years. Patients were followed up for 12 months after discharge. All-cause mortality was the outcome of the study. The ACB score at discharge (0, 1, ≥2) and increasing ACB score from admission to discharge (no increase, +1, +2 or more) were calculated and used as exposure variables. Cox proportional hazards models adjusted for potential confounders were used for the analysis. Interactions between the ACB score and cognitive impairment or history of falls were also investigated.
RESULTS: During the follow-up period, 177 out of 807 participants (21.9%) died. After adjusting for potential confounders, a discharge ACB score of ≥2 (HR 1.69, 95% CI 1.09-2.65) was significantly associated with the outcome, whereas the association between increasing ACB score of +2 or more and mortality was weaker (HR 1.30, 95% CI 0.95-1.92). The interaction between the ACB score at discharge or increasing ACB score and cognitive impairment was statistically significant (P = 0.003 and P = 0.004, respectively), whereas that between the ACB score and falls was not.
CONCLUSIONS: The ACB score at discharge and, to a lesser extent, an increasing ACB score during hospital stay are associated with an increased risk of 1-year mortality in older patients discharged from hospital. Such an association is stronger among patients with cognitive impairment. Geriatr Gerontol Int 2018; 18: 705-713.
© 2018 Japan Geriatrics Society.

Entities:  

Keywords:  anticholinergic burden; cognitive impairment; drugs; falls; mortality

Mesh:

Substances:

Year:  2018        PMID: 29292589     DOI: 10.1111/ggi.13234

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  11 in total

1.  Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?

Authors:  Antonio De Vincentis; Paolo Gallo; Panaiotis Finamore; Claudio Pedone; Luisa Costanzo; Luca Pasina; Laura Cortesi; Alessandro Nobili; Pier Mannuccio Mannucci; Raffaele Antonelli Incalzi
Journal:  Drugs Aging       Date:  2020-08       Impact factor: 3.923

Review 2.  Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.

Authors:  Martin Taylor-Rowan; Olga Kraia; Christina Kolliopoulou; Anna H Noel-Storr; Ahmed A Alharthi; Amanda J Cross; Carrie Stewart; Phyo K Myint; Jenny McCleery; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2022-08-22

Review 3.  Association between anticholinergic drug burden and mortality in older people: a systematic review.

Authors:  Sheraz Ali; Gregory M Peterson; Luke R Bereznicki; Mohammed S Salahudeen
Journal:  Eur J Clin Pharmacol       Date:  2019-12-12       Impact factor: 2.953

4.  Unveiling the Burden of Interactions Among Clinical Risk Factors for 1-Year Mortality in Hospitalized Older Patients.

Authors:  Fabrizia Lattanzio; Valentina Corigliano; Luca Soraci; Alessia Fumagalli; Graziano Onder; Stefano Volpato; Antonio Cherubini; Carmelinda Ruggiero; Annalisa Cozza; Francesco Guarasci; Andrea Corsonello
Journal:  Front Med (Lausanne)       Date:  2021-11-25

5.  Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study.

Authors:  Søren Ramsdal Sørensen; Jeppe Dalskov Frederiksen; Pavithra Laxsen Anru; Tahir Masud; Mirko Petrovic; Jens-Ulrik Rosholm; Jesper Ryg
Journal:  Drugs Real World Outcomes       Date:  2021-08-19

6.  Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.

Authors:  Martin Taylor-Rowan; Sophie Edwards; Anna H Noel-Storr; Jenny McCleery; Phyo K Myint; Roy Soiza; Carrie Stewart; Yoon Kong Loke; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-05

7.  Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study.

Authors:  Patricia Amoros-Reboredo; Dolors Soy; Marta Hernandez-Hernandez; Sabela Lens; Conxita Mestres
Journal:  Int J Environ Res Public Health       Date:  2020-05-26       Impact factor: 3.390

8.  The Prognostic Value of Anticholinergic Burden Measures in Relation to Mortality in Older Individuals: A Systematic Review and Meta-Analysis.

Authors:  Katherine Graves-Morris; Carrie Stewart; Roy L Soiza; Martin Taylor-Rowan; Terence J Quinn; Yoon K Loke; Phyo Kyaw Myint
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

Review 9.  Anticholinergic Drugs in Geriatric Psychopharmacology.

Authors:  Jorge López-Álvarez; Julia Sevilla-Llewellyn-Jones; Luis Agüera-Ortiz
Journal:  Front Neurosci       Date:  2019-12-06       Impact factor: 4.677

Review 10.  Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.

Authors:  Angela Lisibach; Valérie Benelli; Marco Giacomo Ceppi; Karin Waldner-Knogler; Chantal Csajka; Monika Lutters
Journal:  Eur J Clin Pharmacol       Date:  2020-10-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.